TABLE 1.
In vitro activity of fluconazole against 402 clinical yeast isolates as determined by the reference broth microdilution methoda
Organism | No. of isolates tested | MIC (μg/ml)b
|
||
---|---|---|---|---|
Range | 50% | 90% | ||
C. albicans | 161 | 0.25–64 | 1.0 | 4.0 |
C. glabrata | 41 | 1.0–256 | 32 | 128 |
C. tropicalis | 35 | 0.5–8.0 | 2.0 | 4.0 |
C. parapsilosis | 29 | 0.25–64 | 4.0 | 32 |
C. krusei | 32 | 2.0–64 | 64 | 64 |
C. lusitaniae | 31 | 0.25–256 | 2.0 | 8.0 |
Candida speciesc | 19 | 1.0–128 | 4.0 | 64 |
Cryptococcus neoformans | 40 | 2.0–32 | 8.0 | 16 |
Miscellaneous speciesd | 14 | 1.0–>256 | 4.0 | >256 |
All | 402 | 0.25–>256 | 4.0 | 64 |
Performed according to NCCLS M27-A (7).
50% and 90%, MICs at which 50 and 90% of isolates tested, respectively, are inhibited.
Includes C. guilliermondii (n = 5), C. lipolytica (n = 4), C. rugosa (n = 5), C. kefyr (n = 2), and C. zeylanoides (n = 3).
Includes Cryptococcus laurentii (n = 2), C. albidus (n = 1), T. beigelii (n = 4), Rhodotorula spp. (n = 4), and S. cerevisiae (n = 3).